NYSE:STZ

Constellation Brands Inc (STZ)

139.66
-6.64 (4.54%)
as of Jun 29, 2026, 8:00:00 pm Market Open.
79 watching
0
Investor Insights
star iconJun 29, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Constellation Brands Inc (STZ-N) is set to report earnings insights that highlight mixed perspectives from analysts. One expert expresses optimism, showcasing confidence in the newly appointed CEO and anticipating a positive shift in beer and cocktail sales. Conversely, another expert paints a more negative picture, noting that the broader alcohol industry, including Constellation, has struggled recently, facing challenges such as decreased sales driven by ICE raids in key shopping areas. This year, the stock has experienced a significant decline of 36%, with its current price-to-earnings ratio at a notably low 12x. While some view this low valuation as attractive, it is deemed justified due to ongoing weak sales and the emergence of competition from GLP-1 drugs. Overall, while there are signs of potential recovery, significant headwinds linger for Constellation Brands.

consensus icon
Consensus
Mixed
valuation icon
Valuation
Undervalued
review icon
Similar
Diageo,DEO
DON'T BUY

Stock has been sinking for months and faces concerns of the eight-loss drugs impacted their beer sales.

HOLD

Last week, it reported stellar numbers but shares still fell, a victim to persistent misconceptions. Their Modelo is the #1 beer in the US and is gaining market share. Pacifico sales are up 21%. STZ operating margins were up 260 basis points. They beat Q1 EPS. Shares should be selling at $300. The problem is STZ also sells hard liquor, which Wall Street has given up on as well as doubts that beer's popularity is waning. Has huge free cash flow, are buying back shares, and is expanding facilities. Other threats are the weight-loss drugs and the popularity of cannabis. He won't abandon this stock though.

TOP PICK

Leading wine, beer, and spirits. Safe choice. Favourable consumer trends, including moving towards premium offerings. Strong cashflow, will continue buybacks. 11% growth rate. Down 10% from recent highs, chance to buy. Yield is 1.6%, recently raised by 13%.

(Analysts’ price target is $298.80)
BUY

Was upgraded today. Likes it long term given its dividend growth. They did a great job in 2023 during the Bud Light debacle by growing market share, led by Modelo beer. is well-run.

PARTIAL BUY

They report Thursday. They sell the top-selling beer in the US, Modelo. Should report a good quarter. Beer sales have been strong and their flow is flow is good, but STZ needs to pay down debt.

WATCH
The effect of Eli Lilly's diabetes drug which curbs appetite including alcohol.

The drug impacts hard liquor, not beer. Doesn't know why. He's watching this.

BUY

Spirits sales have been weak in the industry the past year, so he greeted STZ's earning today with worry. Beer sales did very well, but not wine and spirits. Still, STZ raised its full-year earnings and cash flow forecast. Shares were up 2% today after an early sell-off.

BUY

Unlike liquor sales, beer sales are healthy. STZ's Mexican beer sales are growing. Their most quarter boasted 12% net sales growth (i.e. Corona, Modelo).

HOLD

Largest beer important company in USA. Shares up 30% in past 5 years. Lots of upside potential. Modest dividend yield. Management appear to be prioritizing revenue growth. Would prefer companies like Walmart. If heading into recession, would be good for defensive investors. 

SELL ON STRENGTH

So-called experts are now urging you to buy this stock, but STZ is already up 17% YTD, having been a huge beneficiary of the problems with Bud Light. Don't be a victim of these momentum chasers. In fact, take some profits now.

BUY
Given their relationship with Canopy Growth

Don't average down. He has little faith in Canopy, but believes in Constellation who delivered a great quarter, but nobody cared. This will change.

BUY

He's long owned this, but the stock has hit several road blocks including a bad investment in cannabis-maker Canopy Growth and the company founders selling huge amounts of shares. he's stuck with it, because he believes in their Mexican beers like Modelo. They just reported solid numbers, like an earnings beat, and a sunny forecast about beer sales even wine/spirits isn't doing as well. Is a long way from last year's highs, but is undervalued.

BUY ON WEAKNESS
California weather is bad, and that's where they sell a lot of their beers. Weather this storm and buy this on dips. Hold long term.
BUY
The owner-family just unloaded some shares, so the stock took a hit recently. However, they keep putting up good numbers, and alcohol endures during a recession/downturn.
BUY
The street has its wrong. They make a ton of money off Corona and other beer brands, but they own a huge stake in Canopy Growth. The Canopy CEO is turning the company around from a money-loser into profits as they expand into the U.S. even if the US doesn't legalize weed federally, STZ no longer needs to report Canopy's losses as its own every quarter. As if weed is legalize, Canopy's gains will benefit STZ.
Showing 16 to 30 of 90 entries